<DOC>
	<DOCNO>NCT01055444</DOCNO>
	<brief_summary>The purpose study explore potential usefulness heat lidocaine 70 mg/tetracaine 70 mg topical patch treatment pain associate shoulder impingement syndrome</brief_summary>
	<brief_title>Study Evaluating Heated Lidocaine/Tetracaine Topical Patch Treatment Patients With Shoulder Impingement Syndrome</brief_title>
	<detailed_description>The purpose single center , 2-week open-label pilot study explore potential usefulness heat lidocaine 70 mg tetracaine 70 mg topical patch treatment pain associate shoulder impingement syndrome . A number efficacy variable employ evaluate utility assess painful response population .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Shoulder Impingement Syndrome</mesh_term>
	<mesh_term>Lidocaine</mesh_term>
	<mesh_term>Tetracaine</mesh_term>
	<criteria>Pain associate shoulder impingement syndrome single shoulder Have tenderness attachment site rotator cuff tendon affect shoulder Have positive Hawkins Neers sign Have use topically applied pain medication target treatment area within 3 day precede Screening/Baseline visit Have use inject pain medication within 14 day precede Screening/Baseline visit Are receive class 1 antiarrhythmic drug ( ie , tocainide , mexiletine , etc . ) Have history and/or past diagnosis severe hepatic disease Other protocoldefined inclusion/exclusion criterion may apply</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2012</verification_date>
</DOC>